These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Neuroleptic malignant syndrome after venlafaxine.
    Author: Nimmagadda SR, Ryan DH, Atkin SL.
    Journal: Lancet; 2000 Jan 22; 355(9200):289-90. PubMed ID: 10675082.
    Abstract:
    A patient developed neuroleptic malignant syndrome after a single dose of venlafaxine with trifluoperazine treatment. A dopamine-inhibition effect induced by one dose of venlafaxine may have augmented dopamine-receptor inhibition by trifluoperazine.
    [Abstract] [Full Text] [Related] [New Search]